In vitro leukemia cell models of Ara-C resistance

Leukemia Research

Volumn 24, Issue 6, 2000, Pages 535-541

  Funato, Tadao ^a   Satou, Junko ^a   Nishiyama, Yuko ^a   Fujimaki, Shinichi ^a   Miura, Toshihiko ^a   Kaku, Mitsuo ^a   Sasaki, Takeshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antisense oligonucleotides; Cytosine arabinoside (Ara C); Deoxycytidine kinase (dCK); Drug resistance; Human leukemia K562 cell; MDR 1

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CYTARABINE; DEOXYCYTIDINE KINASE; DOXORUBICIN; ETOPOSIDE; MULTIDRUG RESISTANCE PROTEIN; PHOSPHOROTHIOIC ACID; VINCRISTINE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANTIMETABOLITES, ANTINEOPLASTIC; CYTARABINE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0034001973     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(00)00016-3     Document Type: Article

References (26)

1. Grant S. Ara-C: cellular and molecular pharmacology. Adv. Cancer Res. 72:1998;197.
2. Norgaard J.M., Langkjer S.T., Palshof T., Clausen N., Pedersen B., Hokland P. Relation of blast cell survival and proliferation to chemotherapy resistance in AML. Br. J. Haematol. 93:1996;888.
3. Benchimol S., Ling V. P-glycoprotein and tumor progression. J. Natl. Cancer Inst. 86:1994;814.
4. Mirski S.E., Gerlach J.H., Cole S.P.C. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res. 47:1987;2594.
5. Popkov M., Lussier I., Medvedkine V., Esteve P.O., Alakhov V., Mandeville R. Multidrug-resistance drug-binding peptides generated by using a phage display library. Eur. J. Biochem. 251:1998;155.
6. Flasshove M., Strumberg D., Ayscue L., Mitchell B.S., Tirier C., Heit W., Seeber S., Schutte J. Structure analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside. Leukemia. 8:1994;780.
7. Ramilo-Torno L.V., Avramis V.I. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines. Cancer Chemother. Pharmacol. 35:1995;191.
8. Fukuda T., Kamishima T., Kakihara T., Ohnishi Y., Suzuki T. Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines. Leuk. Res. 20:1996;931.
9. Kobayashi T., Kakihara T., Uchiyama M., Fukuda T., Kishi K., Shibata A. Low expression of the deoxycytidine kinase (dCK) gene a 1-beta-D-arabinofuranosylcytosine-resistant human leukemic cell line KY-Ra. Leuk. Lymphoma. 15:1994;503.
10. Owens J.K., Shewach D.S., Ullman B., Mitchell B.S. Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene. Cancer Res. 52:1992;2389.
11. Scanlon K.J., Ohta Y., Ishida H., Kijima H., Ohkawa T., Kaminski A., Tsai J., Horng G., Kashani-Sabet M. Oligonucleotide-mediated modulation of mammalian gene expression. FASEB J. 9:1995;1288.
12. Tsuruo T., Iida-Saito H., Kawabata H., Oh-Hara T., Hamada H., Utakoji T. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. Jpn. J. Cancer Res. 77:1986;682.
13. Tsuruo T., Oh-Hara T., Saito T. Characteristics of vincristine resistance in vincristine resistant human myelogeous leukemia K562. AntiCancer Res. 6:1986;637.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55.
15. Ginsburg D., Fox I.H., Mitchell B.S. Cloning and expression of human deoxycytidine kinase cDNA. Proc. Natl. Acad. Sci. USA. 88:1991;1531.
16. Mitsuhashi M., Cooper A., Ogura M., Shinagawa T., Yano K., Hosokawa T. Oligonucleotide probe design - a new approach. Nature. 367:1994;759.
17. Funato T., Yoshida E., Jiao L., Tone T., Kashani-Sabet M., Scanlon K.J. The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomas. Adv. Enzyme Regul. 32:1992;195.
18. Kurosawa M., Okabe M., Hara N., Kawamura K., Suzuki S., Sakurada K., Asaka M. Reversal effect of itraconazole on adriamycin and etoposide resistance in leukemia cells. Ann. Hematol. 72:1996;7.
19. Scanlon K.J., Kashani-Sabet M. Utility of the polymerase chain reaction in detection of gene expression in drug-resistant human tumors. J. Clin. Lab. Anal. 3:1989;323.
20. Inoue K., Sugiyama H., Ogawa H., Nakagawa M., Yamagami T., Miwa H., Kita K., Hiraoka A., Masaoka T., Nasu K., Kyo T., Dohy H., Nakauchi H., Ishidate T., Akiyama T., Kishimoto T. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. 9:1994;3071.
21. Ross D.D., Doyle L.A., Schiffer C.A., Lee E.J., Grant C.E., Cole S.P.C., Deeley R.G., Yang W., Tong Y. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients. Leukemia. 10:1996;48.
22. Li B.D., Budnick R.M., Russo C.A., Anderson G.R., Stewart C.C. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines. J. Surg. Res. 59:1995;485.
23. Fuqua S.A.W., Fitzgerald S.D., McGuire W.L. A simple polymerase chain reaction method for detection and cloning of low-abundance transcripts. Biotechniques. 9:1990;206.
24. Funato T., Ishii T., Kambe M., Scanlon K.J., Sasaki T. Reversal of cisplatin resistance in vivo by an anti-fos ribozyme. In Vivo. 11:1997;217.
25. Takashita A., Shinjo K., Ohnishi K., Ohno R. Expression of multidrug resistance P-glycoprotein in myeloid progenitor cells of different phenotype: comparison between normal bone marrow cells and leukaemia cells. Br. J. Haematol. 93:1996;18.
26. Friedenberg W.R., Spencer S.K., Musser C., Hogan T.F., Rodvold K.A., Rushing D.A., Mazza J.J., Tewksbury D.A., Marx J.J. Multidrug resistance in chronic lymphocytic leukemia. Leuk. Lymphoma. 34:1999;171.